TX200-TR101
TX200-KT02
Phase 2 small_molecule active
Quick answer
TX200-TR101 for Prophylaxis against renal transplant rejection is a Phase 2 program (small_molecule) at SANGAMO THERAPEUTICS, INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- SANGAMO THERAPEUTICS, INC
- Indication
- Prophylaxis against renal transplant rejection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active